New signaling mechanism implicated in the development of ventricular fibrillation

A study led by Guadalupe Sabio and José Jalife at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid has identified a new signaling mechanism implicated in the development of ventricular fibrillation, a type of arrhythmia, or irregular heartbeat.

CEB-01 by Cebiotex for Nerve Sheath Tumor: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Nerve Sheath Tumor.

June 20, 2024

As obesity market heats up, Amgen leaves clues on MariTide’s path forward

Amgen offered a glance at plans for its obesity drug candidate MariTide during its fourth-quarter earnings call, including the extension of an ongoing Phase II

February 8, 2024

Tyrosine Protein Kinase JAK1 drugs in development by Therapy Areas, Indications, Stages, MoA, RoA, Molecule Type, and Key Players, 2023

Share this article The report also covers products from therapy areas such as Immunology, Dermatology, and Gastrointestinal which include the indications Rheumatoid Arthritis, Psoriasis, Atopic

November 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.